Pharmaceutical companies, governments, and the global health care community must...
At a Senate subcommittee hearing Tuesday, members discussed reforms that might a...
Takeda announced that it has voluntarily withdrawn its application to the FDA fo...
A new report resurfaces a thorny challenge in researchers’ quest to turn DNA int...
Digital health funding remained low in the first half of the year as the industr...
Express Scripts will add three biosimilar versions of AbbVie's blockbuster arthr...
Japanese drugmaker Eisai said Tuesday that Ivan Cheung, chairman of its U.S. ope...
Xylazine, which is commonly known as “tranq,” has helped to accelerate the alrea...
We need a more precise, scientific, and shared understanding of just what recove...
“It was very much about following the algorithms and basically not using your cl...
Congress must reauthorize the essential PAHPA framework and enact a disciplined ...
NIH research fellows want to unionize, in large part because they want a raise. ...
Pluri signed a 3-year contract to develop cell therapy to treat acute radiation ...
The European Commission has granted conditional marketing authorisation for Colu...
Iovance Biotherapeutics completes a preliminary analysis after the US' FDA found...
Fulcrum Therapeutics has signed a licence agreement with CAMP4 Therapeutics to d...
